314 related articles for article (PubMed ID: 30465864)
1. The role of dopamine in the brain - lessons learned from Parkinson's disease.
Meder D; Herz DM; Rowe JB; Lehéricy S; Siebner HR
Neuroimage; 2019 Apr; 190():79-93. PubMed ID: 30465864
[TBL] [Abstract][Full Text] [Related]
2. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
[TBL] [Abstract][Full Text] [Related]
3. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
[TBL] [Abstract][Full Text] [Related]
4. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
[TBL] [Abstract][Full Text] [Related]
5. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study.
Ekman U; Eriksson J; Forsgren L; Mo SJ; Riklund K; Nyberg L
Lancet Neurol; 2012 Aug; 11(8):679-87. PubMed ID: 22742929
[TBL] [Abstract][Full Text] [Related]
6. Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease.
Kim K; Bohnen NI; Müller MLTM; Lustig C
Neuroimage; 2019 Apr; 190():94-106. PubMed ID: 29337277
[TBL] [Abstract][Full Text] [Related]
7. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
[TBL] [Abstract][Full Text] [Related]
8. Distinct alterations in Parkinson's medication-state and disease-state connectivity.
Ng B; Varoquaux G; Poline JB; Thirion B; Greicius MD; Poston KL
Neuroimage Clin; 2017; 16():575-585. PubMed ID: 28971008
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease.
Hirano S
Mol Med; 2021 Apr; 27(1):40. PubMed ID: 33858320
[TBL] [Abstract][Full Text] [Related]
10. Executive attention networks show altered relationship with default mode network in PD.
Boord P; Madhyastha TM; Askren MK; Grabowski TJ
Neuroimage Clin; 2017; 13():1-8. PubMed ID: 27896064
[TBL] [Abstract][Full Text] [Related]
11. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
[TBL] [Abstract][Full Text] [Related]
12. Behavioural and neuroimaging correlates of impaired self-awareness of hypo- and hyperkinesia in Parkinson's disease.
Maier F; Williamson KL; Tahmasian M; Rochhausen L; Ellereit AL; Prigatano GP; Kracht L; Tang CC; Herz DM; Fink GR; Timmermann L; Eggers C
Cortex; 2016 Sep; 82():35-47. PubMed ID: 27341471
[TBL] [Abstract][Full Text] [Related]
13. Functional MRI in Parkinson's Disease Cognitive Impairment.
Baggio HC; Junqué C
Int Rev Neurobiol; 2019; 144():29-58. PubMed ID: 30638456
[TBL] [Abstract][Full Text] [Related]
14. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
[TBL] [Abstract][Full Text] [Related]
15. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
Kübler D; Schroll H; Buchert R; Kühn AA
J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
[TBL] [Abstract][Full Text] [Related]
16. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
18. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
[TBL] [Abstract][Full Text] [Related]
19. Cognition in Parkinson's Disease.
O'Callaghan C; Lewis SJG
Int Rev Neurobiol; 2017; 133():557-583. PubMed ID: 28802933
[TBL] [Abstract][Full Text] [Related]
20. Motor-symptom laterality affects acquisition in Parkinson's disease: A cognitive and functional magnetic resonance imaging study.
Huang P; Tan YY; Liu DQ; Herzallah MM; Lapidow E; Wang Y; Zang YF; Gluck MA; Chen SD
Mov Disord; 2017 Jul; 32(7):1047-1055. PubMed ID: 28712121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
